Likita ne kawai ke shiga cikin wajan maganin cututtukan cututtukan cututtukan cututtukan, zabin yana haifar da matsaloli sakamakon illa da rashin illa ga ciki.
Magungunan ƙwayar sukari, irin su Metformin da Maninil, sun bambanta a cikin hanyar aiwatarwa da ƙarfin tasirin hypoglycemic.
Wannan shi ne saboda nau'ikan magunguna, la'akari da fasalin su da bambance-bambance.
Abun ciki
Metformin wani abu ne daga wasu nau'o'in biguanides wadanda ke rage tasirin glucose din jini ta hanyar hanawa shanshi a hanta.
Maninyl ya haɗa da sinadarin glibenclamide, wani sinadarin sulfonylurea na ƙarni na biyu tare da tasirin sukari. Ana yin magunguna kawai a cikin allunan tare da allurai daban-daban na kayan aiki masu aiki.
Aikin magunguna
Ka'idar Metformin ita ce dakatar da gluconeogenesis. Abubuwan yana kunna enzyme na musamman a cikin hanta wanda ke hana ƙarin shigowar glucose cikin jini. Magungunan yana hana juyar da kitse mai mai da kuma inganta iskar shakar su, yana hana shan sukari a cikin hanjin.
Idan aka kwatanta da sauran wakilai na hypoglycemic, magani yana da tasiri sosai wajen hana ci gaban cututtukan cututtukan cututtukan zuciya. Tare da amfani da tsari, magani yana hana karuwar nauyi, kuma lokacin cin abinci, yana taimakawa rage shi.
Allformin Allunan
Magungunan yana hana haɓakar insulin kuma yana sauƙaƙa shigarwar glucose a cikin kyallen ɗan adam. Tare da karancin insulin a cikin jini, abu a alal misali baya nuna kyanwar abubuwan hypoglycemic.
Maninyl yana haɓaka samar da insulin a cikin ƙwayar cuta saboda ƙarar tashoshin potassium a cikin ƙwayoyin beta. Abun da ke cikin ions na potassium yana ƙaruwa, wanda ke ba da ƙwayar ƙwayar jijiya ta zama alama don haɗa sabon insulin.
Magungunan suna da ikon kara martabar metabolism ga hormone, rage hadarin nephropathy da mace-mace. Hanyar aiwatarwa ba ta da alaƙa da yawan glucose a cikin jini, don haka magungunan suna aiki ko da tare da normoglycemia.
Alamu
An wajabta Metformin a matsayin wakili na hypoglycemic da farko don ciwon sukari na 2.
A cikin nau'in cuta na 1 na ciwon sukari, ana iya tsara magani azaman matakan hanawa don haɓakar ciwon sukari na ciwon sukari.
Za'a iya amfani da maganin hypoglycemic don ƙwayar polycystic, idan an lura da hyperinsulinemia da haƙuri glucose.
Ana amfani da Glibenclamide kawai don nau'in mellitus na sukari na 2, lokacin amfani da abinci mai dacewa da isasshen kaya ba zai yiwu ba don rage glucose jini.
Zan iya ɗauka tare?
Don la'akari da yuwuwar haɗuwa da kwayoyi, ya kamata kuyi la'akari da sifofin abubuwan shaye-shaye da hulɗa da abubuwa masu aiki.Sakamakon rage yawan sukari na glibenclamide ya dogara da sashi: mafi girma shine, mafi girman tasirin cutar.
Lokacin da abu mai aiki ya motsa shi, yana fara samar da ƙarin insulin, don haka zaɓi na adadin da ake buƙata na Maninil an ƙaddara shi da sukarin jini.
Lokacin rubuta magani, likita dole ne ya ba da umarni game da abincin da kuma la'akari da adadin carbohydrates a cikin abincin. A matakin farko, farawa yana farawa da mafi ƙarancin yiwuwar magani, kuma bayan gudanarwa, ana lura da tasirin masu cutar sukari.
Idan ya cancanta, ƙara yawan ƙwayoyi. Theauki maganin sau 1-2 a rana, sakamakon abu mai aiki aƙalla 12 hours.
Don haɓaka sakamako na hypoglycemic kuma rage yawan carbohydrates a cikin jini, gudanarwa na Maninil lokaci guda tare da Metformin yana yiwuwa.
Ana amfani da haɗuwa da kwayoyi lokacin da ba zai yiwu ba don cimma nasarar warkewar magani.
Dole ne a sami ƙarin amfani da maganin antidiabetic a cikin likitan likita. A hade tare da wasu magunguna, ana inganta tasirin glibenclamide a jiki.
Wanne ne mafi kyau?
Lokacin da suke rubuta wakili na hypoglycemic, suna jagorantar su ta hanyar tasirin warkewar da ake so, hanyar aiwatar da aiki mai aiki, contraindications na yau don amfani da sakamako masu illa.
Metformin ko Maninil
Wani fasalin Metformin shine cewa tasirin hypoglycemic a jikin mutum bashi da alaƙa da adadin insulin. Manufar maganin shine don hana aiwatar da tasirin glucose.
Metformin shine ɗayan drugsan magunguna waɗanda haɗarin haɓakar haɓakawar jini yana da ƙanƙanci. Baya ga bayyanar cututtukan hanji, kusan maganin ba shi da wata illa. Lactic acidosis na iya faruwa tare da babban yawan abin sama da ya faru kuma idan akwai yuwuwar na koda.
Magungunan Maninil
Sabili da haka, tare da samar da al'ada na kwayar peptide ta hanjin ƙwayar cuta, amma tare da juriya na insulin, Metformin ya fi dacewa.
Rashin daidaituwa ya haɗa da gaskiyar cewa biguanide baya iya rage sukari tare da rashi insulin a cikin jiki. Yin amfani da miyagun ƙwayoyi na dogon lokaci yana hana shan bitamin B12, wanda na ƙarshe zai haifar da ci gaba na myalgia da anemia.
An sanya Glibenclamide don kamuwa da cutar 2 kawai, lokacin da tasirin sauran allunan sukari bai isa ba.
Sinadarin sulfonylurea (glibenclamide) yana da tasirin sakamako masu yawa:
- idan adadin abu mai aiki ya wuce, mummunan jini na iya haɓaka;
- karin nauyi;
- hadin gwiwa zafi
- ciwon kai
- karuwa da hankali;
- zazzabi
- narkewar cuta;
- kasala mai wahala;
- proteinuria (furotin yana fitowa a cikin fitsari);
- cutar cholestatic;
- halayen rashin lafiyan;
- urination akai-akai.
Jerin magungunan rigakafin magunguna kusan iri ɗaya ne, banda cewa glibenclamide an haramta shi gaba ɗaya tare da ciwon sukari da ke dogaro da insulin.
Ba za a iya amfani da Metformin, Maninil ba a cikin lokuta:
- coma mai cutar kansa;
- ciki
- lactation;
- take hakkin hanta da koda;
- bayyanar ketoacidosis;
- yawan tashin hankali.
Ana iya amfani da Glibenclamide tare da taka tsantsan a cikin shan giya, wanda don biguanide ƙayyadaddun iyaka ne.
Bugu da ƙari, ana soke Metformin kwanaki 2 kafin kuma bayan ray, bayan da aka gabatar da bambancin iodinated.
Maninil ko Amaryl
Amaryl kyautar hypoglycemic ne wanda ya danganta da sulfonylureas na mutanen III. Ya ƙunshi sashi mai aiki - glimepiride. Ka'idar aiki ita ce ta yaduwar sakin insulin halittar jini daga cututtukan fata.
Allunan Amaryl
Ba kamar Maninil ba, Amaryl yana da ƙarin sakamako - miyagun ƙwayoyi yana hana gluconeogenesis. Tasirin hypoglycemic na Amaril yafi faɗi kuma aƙalla awa 24.
Ba za a iya sanya maninil da Amaril don kamuwa da cututtukan da suka shafi insulin ba. Lokacin zaɓin kashi na Amaril da magani na gaba, dole ne a la'akari da karatun sukari na jini, tun da akwai yuwuwar samuwar ƙwayar tsoka.
Bayyanannun bayyanar cututtuka daga amfani da kwayoyi da kuma contraindications kusan babu bambanci. Banda ita ce cuta mafi narkewa ta cuta a cikin Amaril, wanda ake dangantawa da aiwatar da maganin gluconeogenesis ta magani.
Bidiyo masu alaƙa
Hanyar aiwatarwa, nau'in sakin layi da ƙarancin amfani da Metformin a cikin bidiyon:
Maninil da Amaryl suna da ƙarfin sakamako na hypoglycemic, amma suna da mahimman jerin sakamako masu illa. Idan ba'a buƙatar ƙarin ƙwayar ƙwayar ƙwayar cuta don samar da insulin ba,
Metformin yana da fa'ida bayyananniya. Yana zuwa mafi girman rage haɗarin atherosclerosis, ba ya haifar da karuwar nauyi kuma yana hana ci gaban cututtukan zuciya. Sakamakon sakamako na narkewa daga ɗaukar narkewa daga ɗaukar biguanide da sauri wuce.
